Next Generation Sequencing (NGS) for Diagnosis and Therapy of Patients with Cancer and Hematological Malignancies
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 12-007850
- Jacksonville, Florida: 12-007850
- Scottsdale/Phoenix, Arizona: 12-007850
Sponsor Protocol Number: 12-007850
About this study
The purpose of this study is to test a new technology called Next Generation Sequencing (NGS) that may help identify potential therapies for certain cancer. NGS is a procedure that looks at all genes. Right now, NGS is only done in outside labs.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients must have a histological or cytological confirmation of a malignancy.
- Patient must have a life expectancy >3 months.
- Patient is a candidate for a core biopsy or surgical procedure to obtain tissue, or there is a quality tissue sample available from which DNA and RNA can be obtained.
- Patients must understand and provide written informed consent and HIPAA authorization prior to initiation of any study-specific procedures, or have a parent/legal guardian able to do so.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Robert McWilliams, M.D. |
Closed for enrollment |
|
Jacksonville, Fla.
Mayo Clinic principal investigator Robert McWilliams, M.D. |
Closed for enrollment |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Robert McWilliams, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available